As vaccination programmes in the developing world lag behind richer nations’ efforts, a drug called ivermectin, commonly used for treating skin conditions and parasites in livestock, has shown some promise.
While data is still emerging about its effectiveness for COVID-19 patients, early trials across the developing world suggest that it may be useful.
Al Jazeera’s Jonah Hull reports from London, the UK.
– Subscribe to our channel: http://aje.io/AJSubscribe
– Follow us on Twitter: https://twitter.com/AJEnglish
– Find us on Facebook: https://www.facebook.com/aljazeera
– Check our website: https://www.aljazeera.com/
#COVID19vaccine #Ivermectin #AljazeeraEnglish